Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 12, Pages e51461
Publisher
Public Library of Science (PLoS)
Online
2012-12-12
DOI
10.1371/journal.pone.0051461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SMAC Mimetic (JP1201) Sensitizes Non-Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF- -Independent Manner
- (2011) R. M. Greer et al. CANCER RESEARCH
- c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
- (2011) Hanning You et al. HEPATOLOGY
- Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
- (2011) Uzma Asghar et al. JOURNAL OF HEPATOLOGY
- Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
- (2011) J. Lu et al. MOLECULAR CANCER THERAPEUTICS
- IAP Regulation of Metastasis
- (2010) Swarna Mehrotra et al. CANCER CELL
- Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
- (2010) Sean P. Dineen et al. CANCER RESEARCH
- Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner
- (2010) B L Probst et al. CELL DEATH AND DIFFERENTIATION
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation
- (2010) Terence Kin Wah Lee et al. HEPATOLOGY
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
- (2009) Claudia Augello et al. BMC CANCER
- Down-regulation of c-FLIP Enhances Death of Cancer Cells by Smac Mimetic Compound
- (2009) H. H. Cheung et al. CANCER RESEARCH
- Targeting of the Akt-Nuclear Factor- B Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
- (2009) H. A. Omar et al. MOLECULAR PHARMACOLOGY
- Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance
- (2008) M. Fakler et al. BLOOD
- SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP
- (2008) J. Lu et al. CANCER RESEARCH
- Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
- (2008) Ying-Hong Shi et al. HEPATOLOGY
- IAPs: What's in a Name?
- (2008) Srinivasa M. Srinivasula et al. MOLECULAR CELL
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC
- (2007) Qiuwei Pan et al. ACTA ONCOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started